JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Pediatric molluscum contagiosum: reflections on the last challenging poxvirus infection, Part 1.

Molluscum contagiosum (MC) is a common dermatologic infection that usually affects school-aged children, sexually active young adults, and immunocompromised individuals. It is a benign and self-limiting disease, with most cases undergoing spontaneous resolution within 6 to 9 months. However, a more severe and prolonged course is associated with immunosuppression or atopic dermatitis (AD). Management can be challenging; it needs to be decided whether to treat MC or let it run its natural course. It may be managed with reassurance and benign neglect; however, therapeutic intervention may be indicated to prevent autoinoculation and transmission, especially in patients at risk for severe disease. Guardians concerned about cosmesis should understand that therapy may leave pigmentary alterations and sometimes scars. The 3 major therapeutic modalities employed are physical destruction, immunomodulation, and antiviral agents. Combinations of these therapies may be employed. Therapeutic modalities will be discussed in part 2.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app